![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Pharmacokinetic Interaction Between Methadone and the Investigational HCV Protease Inhibitor Telaprevir
|
|
|
Reported by Jules Levin
46th Annual Meeting of the European Association for the Study of the Liver (The International Liver CongressTM 2011), Berlin, Germany, 30 March-3 April 2011
Rolf van Heeswijk,1 Ann Vandevoorde,1 Peter Verboven,2 Griet Boogaerts,1 Els De Paepe,1 Rodica van Solingen-Ristea,1 Varun Garg,3 Maria Beumont1
1Tibotec BVBA, Beerse, Belgium; 2Janssen Research and Development, Beerse, Belgium; 3Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA
![AASLD1.gif](../images/120711/120711-1/AASLD1.gif)
![AASLD2.gif](../images/120711/120711-1/AASLD2.gif)
![AASLD3.gif](../images/120711/120711-1/AASLD3.gif)
![AASLD4.gif](../images/120711/120711-1/AASLD4.gif)
![AASLD5.gif](../images/120711/120711-1/AASLD5.gif)
![AASLD6.gif](../images/120711/120711-1/AASLD6.gif)
![AASLD7.gif](../images/120711/120711-1/AASLD7.gif)
![AASLD8.gif](../images/120711/120711-1/AASLD8.gif)
![AASLD9.gif](../images/120711/120711-1/AASLD9.gif)
![AASLD10.gif](../images/120711/120711-1/AASLD10.gif)
![AASLD11.gif](../images/120711/120711-1/AASLD11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|